Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
76,851,274
-
Total 13F shares
-
76,712,487
-
Share change
-
+410,667
-
Total reported value
-
$2,576,155,081
-
Put/Call ratio
-
47%
-
Price per share
-
$33.55
-
Number of holders
-
206
-
Value change
-
+$10,185,348
-
Number of buys
-
88
-
Number of sells
-
95
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q1 2025
As of 31 Mar 2025,
Xenon Pharmaceuticals Inc. - Common Stock (XENE) was held by
206 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
76,712,487 shares.
The largest 10 holders included
FMR LLC, Avoro Capital Advisors LLC, Driehaus Capital Management LLC, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, Capital International Investors, BRAIDWELL LP, Polar Capital Holdings Plc, COMMODORE CAPITAL LP, and Capital World Investors.
This page lists
206
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.